FDA Inspection 1098794 — St. Luke's IRB
The FDA completed an inspection of St. Luke's IRB on July 18, 2019 in Duluth, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 18, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Duluth, MN (United States)
Additional Details
IRB